Navigation Links
Mirati Therapeutics Reports Second Quarter 2014 Financial Results and Provides Business Update
Date:8/8/2014

SAN DIEGO, Aug. 8, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX) today reported financial results for the second quarter ended June 30, 2014 and provided an update on its drug development programs.

"In the past quarter we expanded the scope of our clinical programs, identified compelling patient selection strategies targeting driver mutations, and positioned the company to obtain initial data by the end of the year from multiple proof of concept studies," said Charles M. Baum, M.D., Ph.D., president and CEO of Mirati. "We have made significant strides in executing on our precision oncology strategy and are looking forward to achieving significant milestones within each of our programs."

Second Quarter 2014 Business UpdateMGCD265

  • Phase 1 safety and dose escalation study ongoing
  • Planning to initiate expansion cohorts with a goal of obtaining initial proof of concept data by the end of 2014 in patients who have genetic alterations in Met and Axl
  • MGCD516

  • Phase 1 safety and dose escalation study initiated
  • On track to identify a Phase 2 dose by the end of 2014
  • Mocetinostat

  • Secured orphan drug designation for mocetinostat in myelodysplastic syndromes; orphan applications for bladder cancer and diffuse large b-cell lymphoma (DLBCL) have been submitted
  • The mocetinostat Phase 2 dose confirmation trial is ongoing and the mocetinostat Phase 2 trials in bladder cancer and DLBCL will commence in Q3 with the goal of obtaining initial proof of concept data by the end of 2014
  • Second Quarter 2014 Financial Results Cash, cash equivalents, and short-term investments were $47.4 million at June 30, 2014, compared to $62.1 million at December 31, 2013.

    Research and development expenditures for the second quarter of 2014 were $7.2 million, compared to $4.5 million for the
    '/>"/>

    SOURCE Mirati Therapeutics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Mirati Presents Clinical Response Results of Mocetinostat in Combination with Azacitidine as a Treatment for MDS
    2. Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
    3. Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
    4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
    5. Mirati Therapeutics Prices Public Offering Of Common Stock
    6. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
    7. Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
    8. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
    9. Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
    10. Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
    11. PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... , July 6, 2015   Cepheid (Nasdaq: ... financial results for its 2015 second quarter ended June ... close of the market. The Company will ... on Thursday, July 23, 2015, to discuss the results.  ... at http://ir.cepheid.com at least 15 minutes before ...
    (Date:7/6/2015)... China , July 6, 2015 China Information ... a leading provider of integrated cloud-based platform, exchange, and ... today announced that the Company launched its mobile app ... of accessible healthcare services on mobile devices. The Company ... Health and Family Planning Bureau and Shenzhen News Net.   ...
    (Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
    Breaking Medicine Technology:CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
    ... a clear victory for consumers and employers, the Maine ... law mandating fiduciary-disclosure requirements on pharmacy benefit managers (PBMs).  ... state-prescribed contract model for pharmacy benefits and also required ... and their health plan and employer clients. ...
    ... (NYSE: HRC ) will release its fiscal 2011 ... will host a webcast the following morning on Thursday, July ... Release:   Hill-Rom,s Fiscal 2011 Third Quarter Earnings Release for ... the public after the close of the NYSE on Wednesday, ...
    Cached Medicine Technology:Win for Consumers and Payers: Maine Repeals Costly PBM Fiduciary-Disclosure Law 2Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast 2
    (Date:7/6/2015)... ... ... “ TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... what rooms will look like before they even start renovating.. , Whether a person ...
    (Date:7/6/2015)... ... July 06, 2015 , ... ... orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine ( AOSSM ) ... 9-12 in Orlando, FL. As a leader in orthopaedic sports medicine, AOSSM ...
    (Date:7/6/2015)... ... 2015 , ... Shortly after opening her second practice in Signal Hill, Dr. ... on a lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, ... refugees, Dr. Lim suffered with back pain herself throughout high school. Unaware of ...
    (Date:7/6/2015)... ... July 06, 2015 , ... Invitation ... midwives, yet there is a large gap between the unmet health priorities in ... improve health outcomes and reduce unnecessary or ineffective treatments or procedures. , This ...
    (Date:7/6/2015)... London, UK (PRWEB) , ... July 06, 2015 , ... ... 5.58 billion in 2014. It is expected to grow at a CAGR of over ... by 2021. , The growth is likely to be mainly spurred by an anticipated ...
    Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
    ... discovery may help treat stroke-affected humans New York, A ... stroke by stimulating a protein// on the surface of ... repairing the human body afflicted with severe injuries such ... on rats suggests that in humans it could be ...
    ... Associate Health Minister Jim Anderton said that the Government's suicide ... ,New Zealand has a very high youth suicide rate ... rates. According to the statistics 80 % of the 515 ... among men aged 80-84 were the highest. The 10-year plan ...
    ... implants better will be his or her spoken language skills, sentence ... child, born as deaf but used cochlear implants, able to hear ... of it. ,In contrast, a child of the same ... sophisticated statements: ‘OK, now the people goes to stand there with ...
    ... of three diagnostic methods used in assessing blunt abdominal ... high //diagnostic value than the other two methods. ... medicine, and radiology at the University of Bologna in ... sonography and CT in the assessment of blunt abdominal ...
    ... Institutes of Health panel ruled that there was not need ... a method of reducing risk of HIV infection. ... study after an early look at the data, which showed ... 60 percent. Scientists finding that the protective effect was so ...
    ... Pittsburgh School of Medicine has indicated smokers, smoking the ... than other smokers//. ,Researchers in the US ... due to the supposedly low-tar and low-nicotine brands might ... one third of the people smoking lights had chosen ...
    Cached Medicine News:Health News:Earlier the Cochlear Implants Used Better the Speech 2Health News:Earlier the Cochlear Implants Used Better the Speech 3Health News:CE Sonography Score Over Others in Blunt Abdominal Trauma Assessment 2Health News:Circumcision Studies to Continue Says Health Panel 2Health News:Light & Mild Cigarettes Just As Harmful As Regular Ones 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: